These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 19652126)

  • 21. Relationship between nicotinic receptors and cognitive function in early Alzheimer's disease: a 2-[18F]fluoro-A-85380 PET study.
    Ellis JR; Villemagne VL; Nathan PJ; Mulligan RS; Gong SJ; Chan JG; Sachinidis J; O'Keefe GJ; Pathmaraj K; Wesnes KA; Savage G; Rowe CC
    Neurobiol Learn Mem; 2008 Sep; 90(2):404-12. PubMed ID: 18620875
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent PET radioligands with optimal brain kinetics for imaging nicotinic acetylcholine receptors.
    Horti AG; Kuwabara H; Holt DP; Dannals RF; Wong DF
    J Labelled Comp Radiopharm; 2013; 56(3-4):159-66. PubMed ID: 24285321
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Validation of an extracerebral reference region approach for the quantification of brain nicotinic acetylcholine receptors in squirrel monkeys with PET and 2-18F-fluoro-A-85380.
    Le Foll B; Chefer SI; Kimes AS; Shumway D; Goldberg SR; Stein EA; Mukhin AG
    J Nucl Med; 2007 Sep; 48(9):1492-500. PubMed ID: 17704243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 5-(123)I-A-85380 binding to the α4β2-nicotinic receptor in mild cognitive impairment.
    Terrière E; Dempsey MF; Herrmann LL; Tierney KM; Lonie JA; O'Carroll RE; Pimlott S; Wyper DJ; Herholz K; Ebmeier KP
    Neurobiol Aging; 2010 Nov; 31(11):1885-93. PubMed ID: 19036475
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantification of nicotinic acetylcholine receptors in Parkinson's disease with (123)I-5IA SPECT.
    Oishi N; Hashikawa K; Yoshida H; Ishizu K; Ueda M; Kawashima H; Saji H; Fukuyama H
    J Neurol Sci; 2007 May; 256(1-2):52-60. PubMed ID: 17367812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Noninvasive evaluation of nicotinic acetylcholine receptor availability in mouse brain using single-photon emission computed tomography with [(123)I]5IA.
    Matsuura Y; Ueda M; Higaki Y; Watanabe K; Habara S; Kamino S; Saji H; Enomoto S
    Nucl Med Biol; 2016 Jun; 43(6):372-8. PubMed ID: 27260778
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nicotinic α4β2 receptor imaging agents. Part III. Synthesis and biological evaluation of 3-(2-(S)-azetidinylmethoxy)-5-(3'-18F-fluoropropyl)pyridine (18F-nifzetidine).
    Pichika R; Easwaramoorthy B; Christian BT; Shi B; Narayanan TK; Collins D; Mukherjee J
    Nucl Med Biol; 2011 Nov; 38(8):1183-92. PubMed ID: 21831652
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cholinergic Receptor Binding in Alzheimer Disease and Healthy Aging: Assessment In Vivo with Positron Emission Tomography Imaging.
    Sultzer DL; Melrose RJ; Riskin-Jones H; Narvaez TA; Veliz J; Ando TK; Juarez KO; Harwood DG; Brody AL; Mandelkern MA
    Am J Geriatr Psychiatry; 2017 Apr; 25(4):342-353. PubMed ID: 28162919
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Graphical analysis of 2-[18F]FA binding to nicotinic acetylcholine receptors in rhesus monkey brain.
    Chefer SI; London ED; Koren AO; Pavlova OA; Kurian V; Kimes AS; Horti AG; Mukhin AG
    Synapse; 2003 Apr; 48(1):25-34. PubMed ID: 12557269
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decrease of nicotinic receptors in the nigrostriatal system in Parkinson's disease.
    Kas A; Bottlaender M; Gallezot JD; Vidailhet M; Villafane G; Grégoire MC; Coulon C; Valette H; Dollé F; Ribeiro MJ; Hantraye P; Remy P
    J Cereb Blood Flow Metab; 2009 Sep; 29(9):1601-8. PubMed ID: 19491921
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Smoking upregulates alpha4beta2* nicotinic acetylcholine receptors in the human brain.
    Wüllner U; Gündisch D; Herzog H; Minnerop M; Joe A; Warnecke M; Jessen F; Schütz C; Reinhardt M; Eschner W; Klockgether T; Schmaljohann J
    Neurosci Lett; 2008 Jan; 430(1):34-7. PubMed ID: 17997038
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 18F-ZW-104: a new radioligand for imaging neuronal nicotinic acetylcholine receptors--in vitro binding properties and PET studies in baboons.
    Valette H; Xiao Y; Peyronneau MA; Damont A; Kozikowski AP; Wei ZL; Kassiou M; Kellar KJ; Dollé F; Bottlaender M
    J Nucl Med; 2009 Aug; 50(8):1349-55. PubMed ID: 19652217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High density of nicotinic receptors in the cingulo-insular network.
    Picard F; Sadaghiani S; Leroy C; Courvoisier DS; Maroy R; Bottlaender M
    Neuroimage; 2013 Oct; 79():42-51. PubMed ID: 23631995
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Imaging α4β2 Nicotinic Acetylcholine Receptors (nAChRs) in Baboons with [
    Kuwabara H; Gao Y; Stabin M; Coughlin J; Nimmagadda S; Dannals RF; Pomper MG; Horti AG
    Mol Imaging Biol; 2017 Apr; 19(2):280-288. PubMed ID: 27562686
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantification of human nicotinic acetylcholine receptors with 123I-5IA SPECT.
    Mamede M; Ishizu K; Ueda M; Mukai T; Iida Y; Fukuyama H; Saga T; Saji H
    J Nucl Med; 2004 Sep; 45(9):1458-70. PubMed ID: 15347712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cerebral glucose metabolism of Parkinson's disease patients with mild cognitive impairment.
    Lyoo CH; Jeong Y; Ryu YH; Rinne JO; Lee MS
    Eur Neurol; 2010; 64(2):65-73. PubMed ID: 20606450
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 6-[18F]fluoro-A-85380, a novel radioligand for in vivo imaging of central nicotinic acetylcholine receptors.
    Horti AG; Chefer SI; Mukhin AG; Koren AO; Gündisch D; Links JM; Kurian V; Dannals RF; London ED
    Life Sci; 2000 Jun; 67(4):463-9. PubMed ID: 11003056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo imaging of human cerebral nicotinic acetylcholine receptors with 2-18F-fluoro-A-85380 and PET.
    Gallezot JD; Bottlaender M; Grégoire MC; Roumenov D; Deverre JR; Coulon C; Ottaviani M; Dollé F; Syrota A; Valette H
    J Nucl Med; 2005 Feb; 46(2):240-7. PubMed ID: 15695782
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cortical 6-[18F]fluoro-L-dopa uptake and frontal cognitive functions in early Parkinson's disease.
    Brück A; Aalto S; Nurmi E; Bergman J; Rinne JO
    Neurobiol Aging; 2005 Jun; 26(6):891-8. PubMed ID: 15718048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced muscarinic type 2 receptor binding in subjects with bipolar disorder.
    Cannon DM; Carson RE; Nugent AC; Eckelman WC; Kiesewetter DO; Williams J; Rollis D; Drevets M; Gandhi S; Solorio G; Drevets WC
    Arch Gen Psychiatry; 2006 Jul; 63(7):741-7. PubMed ID: 16818863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.